Saturday, July 4, 2009

Jenburkt Pharmaceuticals Ltd.

Jenburkt Pharmaceuticals Ltd.
BSE Code: 524731
Last Close: Rs.27
Jenburkt Pharmaceuticals Ltd. (JPL), a diversified venture into healthcare and pharmaceuticals was formed in 1985 by the Bhuta family. It manufactures & markets speciality and high quality pharmaceutical formulations and healthcare products. The company has state-of-the-art manufacturing plants at Sihor in Gujarat. It has adequate capacities for manufacturing
world-class pharmaceuticals and healthcare products. JPL has an equity of Rs.4.65 cr. in which the promoters hold 41.67% and the investing public holds 53.47%. For Q4FY09, it reported a net profit of Rs.1.33 cr. against Rs.60 lakh in FY08 and declared 18% dividend. At current levels,
the stock is available cum dividend. The company has announced 25 July 2009 as book closure for dividend right. Buy with a stop loss of Rs.23. On the upper side, the stock will go up to Rs.32-35 levels in coming days.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.